Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report

Saved in:
Bibliographic Details
Published in:Lung Cancer: Targets and Therapy
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301673914859520
collection WordPress RSS
FRELIP Feed Integration
container_title Lung Cancer: Targets and Therapy
description
discipline_display Respiratory Diseases
discipline_facet Respiratory Diseases
format Online Article
RSS Article
genre Journal Article
id rss_article:58415
institution FRELIP
journal_source_facet Lung Cancer: Targets and Therapy
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
Respiratory Diseases
General
Respiratory Diseases
sub_discipline_display General
sub_discipline_facet General
subject_display Respiratory Diseases
General
Respiratory Diseases
Respiratory Diseases
General
Respiratory Diseases
subject_facet Respiratory Diseases
General
Respiratory Diseases
title Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
title_auth Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
title_full Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
title_fullStr Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
title_full_unstemmed Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
title_short Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
title_sort incretin receptor agonist, semaglutide, as a treatment for alectinib-induced excessive weight gain. a case report
topic Respiratory Diseases
General
Respiratory Diseases
url https://www.dovepress.com/incretin-receptor-agonist-semaglutide-as-a-treatment-for-alectinib-ind-peer-reviewed-fulltext-article-LCTT